今天國際(300532.SZ):公司合作客户中目前沒有醫院
格隆匯5月29日丨有投資者在投資者互動平台向今天國際(300532.SZ)提問,“現在醫院裏,特別是醫院藥房裏的智能物流應用得多起來了,請問公司有這方面的業務嗎?”
公司回覆稱,公司合作客户中目前沒有醫院。公司在醫藥行業的標杆項目——廣州醫藥智慧物流中心項目,該項目是粵港澳大灣區醫藥供應鏈物流覆蓋體系建設的重要樞紐,規模大複雜程度高,項目的順利實施體現了公司豐富的行業經驗沉澱,代表公司在醫藥行業邁出的堅實一步,公司期待助力更多醫藥企業和醫院方進行物流體系改造升級,與各方一同推動醫藥供應鏈的高質量發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.